YOLFTbeta
MediciNova Inc

MediciNova Inc

MNOV · NASDAQ · Healthcare / Biotechnology

1.40USD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close1.40
Open1.40
Day Range1.39 – 1.45
52-Week Range1.17 – 3.90
Volume61.60K
Market Cap126.99M
P/E (TTM)0.00
Forward P/E8.53
EPS-0.21
Dividend Yield0.00%
Beta0.63
50-Day Avg1.66
200-Day Avg1.49

About

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Yuichi Iwaki M.D., Ph.D.
  • Employees6
  • Headquarters4275 Executive Square, La Jolla, CA, United States, 92037, USA
  • Websitehttps://medicinova.com

Leadership

  • Dr. Yuichi Iwaki M.D., Ph.D.Co-Founder, President, CEO & Chairman · b. 1950
  • Dr. Kazuko Matsuda M.D., M.P.H., Ph.D.Senior VP, Chief Medical Officer & Director · b. 1966
  • Dr. David H. Crean M.B.A., Ph.D.Chief Business Officer · b. 1965
  • Mr. Jason J. Kruger CPACFO & Principal Financial Officer · b. 1978

Financials

Income Statement

Currency: USD2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue---490.28K804.07K263.88K263.88M---0802.58K6.00M0000004.00M4.04M01.00M0409.66K
Growth (%)----+64.00%-67.18%+99900.00%-----+647.99%-100.00%------+0.94%-100.00%--100.00%-
Cost of Revenue---437.58K674.23K146.61K146.61M---011.71M9.99M026.70K14.13K28.10K25.88K23.94K21.34K-212.43K20.30K21.08K378.61K
Gross Profit---52.70K129.84K117.27K117.27M---0802.58K6.00M0-26.70K-14.13K-28.10K-25.88K-23.94K-21.34K4.04M-212.43K1.00M-21.08K31.05K
Gross Margin---10.75%16.15%44.44%44.44%----100.00%100.00%-------0.53%100.00%-100.00%-7.58%
Operating Expense---48.67M30.22M41.79M170.76M---16.11M11.75M10.02M9.22M8.80M10.87M13.00M15.56M14.01M14.16M14.25M14.42M10.90M12.65M13.31M
Operating Income-2.02M-7.01M-6.26M-48.61M-30.09M-41.68M-53.49M-22.60M-21.24M-17.88M-16.11M-10.95M-4.02M-9.22M-8.82M-10.88M-13.03M-15.59M-14.03M-14.18M-10.22M-14.63M-9.90M-12.68M-13.28M
Operating Margin----9915.19%-3741.93%-15794.30%-20.27%-----1363.77%-66.97%-------354.46%-253.02%--990.03%--3242.47%
EBITDA-2.02M-7.09M-6.28M-48.23M-25.54M-41.68M-48.37M-21.61M-20.14M-19.08M-16.09M-10.88M-3.92M-9.18M-8.80M-10.87M-13.00M-15.56M-14.01M-14.16M-10.11M-14.05M-8.55M-11.02M-11.97M
EBITDA Margin----9836.65%-3176.31%-15794.30%-18.33%-----1355.71%-65.36%-------353.92%-250.29%--854.82%--2922.41%
Net Income-1.79M-6.93M-6.21M-48.27M-25.69M-35.69M-48.90M-21.92M-20.37M-20.19M-17.73M-10.96M-4.03M-9.20M-8.85M-10.87M-11.16M-14.68M-12.94M-13.85M-10.13M-14.07M-8.57M-11.05M-12.00M
Net Income Margin----9845.89%-3195.27%-13525.09%-18.53%-----1365.76%-67.11%-------346.35%-251.00%--857.15%--2928.78%
R&D952.00K5.55M4.72M11.32M22.74M32.17M42.12M13.83M10.87M9.71M7.78M5.01M3.37M3.26M3.02M3.52M4.22M5.63M6.08M7.49M8.10M9.14M5.66M7.20M7.16M
R&D as % of Total Revenue---2308.27%2827.90%12191.61%15.96%----624.62%56.07%------187.13%200.62%-565.83%-1746.65%
Interest Expense0000000001.77M1.60M0062851445429801.10M322.78K84.13K562.39K---
Interest Expense % of Total Revenue---0.00%0.00%0.00%0.00%----0.00%0.00%------8.07%2.08%----

Balance Sheet

Currency: USD2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets8.38M1.59M5.63M53.77M142.39M111.59M73.75M50.22M94.33M72.93M30.79M19.57M29.55M27.27M37.91M39.81M43.42M77.22M79.21M75.42M87.41M74.15M66.27M55.88M45.60M
Total Liabilities325.00K464.00K1.06M46.10M6.69M10.61M7.14M2.18M54.31M48.23M7.29M4.69M4.12M5.26M5.15M5.28M4.78M4.12M4.31M4.09M3.73M3.91M3.89M3.37M4.02M
Total Equity8.05M1.12M4.57M7.67M135.71M100.98M66.61M48.04M40.01M24.70M23.50M14.88M25.43M22.01M32.75M34.53M38.64M73.11M74.89M71.33M83.68M70.24M62.38M52.50M41.59M
Cash--4.24M38.80M37.68M8.33M18.78M19.30M19.24M28.25M15.09M4.01M6.70M11.67M22.08M24.12M27.99M62.31M63.79M60.04M71.43M18.51M51.00M40.36M30.81M
Total Debt--------46.86M43.06M---18.75M12.68M967.00K-27.21M399.35K184.75K826.64K681.12K215.93K193.77K194.33K
Net Debt---4.24M-38.80M-37.68M-8.33M-18.78M-19.30M27.62M14.81M-15.09M-4.01M-6.70M7.08M-9.40M-23.15M-27.99M-35.10M-63.39M-59.85M-70.60M-17.82M-50.78M-40.17M-30.61M

Cash Flow

Currency: USD2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-5.93M-13.55M-22.88M-34.06M-43.86M-21.12M-17.01M-17.70M-13.31M-11.86M-10.65M816.53K-7.15M-6.55M-6.92M-9.11M-9.12M-10.83M-9.38M-12.91M-7.43M-10.64M-9.81M
Investing Cash Flow-1.07M-11.07M-89.15M5.81M43.63M21.55M-1.14M27.64M-6.08K-763.38K-36.75K-3.52K-2.32K-84.48K-84.48M626.32K-11.27K-36.49K-28.73K-40.01M39.91M-697-2.90K
Financing Cash Flow9.96M59.18M110.91M-1.09M10.67M86.73K18.09M-926.65K155.66K1.55M13.37M4.16M17.56M8.67M10.80M42.81M10.62M7.11M20.78M7.92K32.46B0244.02K
Capital Expenditure10.54K321.24K978.56K209.00K380.71K016.45K18.56K6.08K83.38K41.55K3.52K2.32K84.48K10.20K10.20K11.27K36.49K28.73K5.01K21.30K8952.90K
Free Cash Flow-5.94M-13.87M-23.86M-34.27M-44.24M-21.12M-17.03M-17.72M-13.31M-11.95M-10.69M813.01K-7.15M-6.63M-6.92M-9.12M-9.14M-10.86M-9.41M-12.92M-7.45M-10.64M-9.81M
Dividends Paid-------37.46M0000000--------
FCF to OCF100.18%102.37%104.28%100.61%100.87%100.00%100.10%100.10%100.05%100.70%100.39%99.57%100.03%101.29%100.00%100.11%100.12%100.34%100.31%100.04%100.29%100.01%100.03%
Dividend Paid to FCF--------211.44%0.00%0.00%0.00%0.00%0.00%0.00%0.00%--------

Earnings

Report DateFeb 15, 2007May 10, 2007Aug 9, 2007Nov 9, 2007Mar 17, 2008May 12, 2008Aug 11, 2008Nov 10, 2008Mar 31, 2009May 15, 2009Aug 14, 2009Nov 12, 2009Mar 24, 2010May 17, 2010Aug 16, 2010Nov 15, 2010Mar 31, 2011May 16, 2011Aug 16, 2011Nov 15, 2011Mar 29, 2012May 10, 2012Aug 9, 2012Nov 8, 2012Mar 28, 2013May 8, 2013Aug 8, 2013Nov 7, 2013Mar 28, 2014May 12, 2014Aug 11, 2014Nov 13, 2014Mar 12, 2015May 11, 2015Jul 30, 2015Oct 29, 2015Feb 25, 2016Apr 27, 2016Jul 26, 2016Oct 25, 2016Feb 14, 2017Apr 26, 2017Jul 26, 2017Oct 23, 2017Feb 13, 2018Apr 25, 2018Jul 23, 2018Oct 25, 2018Feb 13, 2019Apr 25, 2019Jul 25, 2019Oct 25, 2019Feb 13, 2020Apr 23, 2020Jul 28, 2020Oct 26, 2020Feb 19, 2021May 13, 2021Aug 12, 2021Nov 12, 2021Feb 16, 2022May 12, 2022Aug 11, 2022Nov 10, 2022Feb 16, 2023May 11, 2023Aug 9, 2023Nov 9, 2023Feb 15, 2024May 9, 2024Aug 8, 2024Nov 13, 2024Feb 19, 2025May 13, 2025Aug 14, 2025Nov 12, 2025Feb 20, 2026May 14, 2026Aug 13, 2026Nov 11, 2026
EPS Estimate-0.61--1.10-0.90-0.95-0.67-0.97-1.040.17-0.26-0.39-0.46-0.43-0.46-0.37-0.32-0.40-0.33-0.33-0.34-0.24-0.28-0.26-0.17-0.14-0.13-0.11----0.09-0.08-0.09-0.10-0.09-0.10-0.08-0.07-0.07-0.05-0.07-0.09-0.09-0.08-0.09-0.09-0.10-0.11-0.14-0.09-0.10-0.13-0.08-0.08-0.10-0.11-0.03-0.09-0.09-0.09-0.09-0.10-0.07-0.08-0.08-0.07-0.07-0.08-0.08-0.05-0.06-0.06-0.05-0.14-0.12-0.12-0.09-0.06-0.06-0.06
EPS Actual-1.13-1.40-1.68-0.87-0.25-0.66-0.33-0.40-0.29-0.41-0.40-0.40-0.49-0.42-0.35-0.39-0.40-0.42-0.31-0.25-0.22-0.24-0.14-0.14-0.14-0.14-0.14-0.100.14-0.10-0.09-0.10-0.10-0.09-0.09-0.06-0.09-0.11-0.10-0.08-0.04-0.09-0.08-0.11-0.05-0.12-0.08-0.16-0.01-0.11-0.09-0.05-0.05-0.06-0.10-0.08-0.06-0.00-0.09-0.07-0.04-0.07-0.08-0.07-0.06-0.06-0.06-0.01-0.04-0.06-0.05-0.06-0.06-0.06-0.07-0.06-0.05-0.05-0.05-
Surprise-85.25%--52.73%3.33%73.68%1.49%65.98%61.54%-270.59%-57.69%-2.56%13.04%-13.95%8.70%5.41%-21.88%0.00%-27.27%6.06%26.47%8.33%14.29%46.15%17.65%0.00%-7.69%-27.27%---2.33%-25.00%-11.11%10.00%0.00%40.00%-12.50%-57.14%-42.86%-60.00%42.86%0.00%11.11%-37.50%44.44%-33.33%20.00%-45.45%96.43%-22.22%10.00%61.54%37.50%25.00%0.00%27.27%-100.00%95.56%0.00%22.22%55.56%30.00%-14.29%12.50%25.00%14.29%14.29%87.50%50.00%-20.00%16.67%0.00%-20.00%57.14%41.67%50.00%44.44%16.67%16.67%-
TimingAfter-hours-After-hoursPre-market-After-hoursAfter-hoursAfter-hoursAfter-hours-Pre-marketAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursPre-marketPre-marketPre-market-After-hoursAfter-hours-After-hoursAfter-hours----After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hours-

Key Statistics & Ratios

Market Cap126.99M
Enterprise Value111.54M
Trailing P/E0.00
Forward P/E8.53
PEG Ratio-0.94
Price / Sales137.96
Price / Book3.67
EPS-0.21
Book Value0.757
Revenue (TTM)920.48K
Gross Profit (TTM)347.44K
EBITDA-11.83M
Profit Margin0.00%
Operating Margin-554.31%
Return on Equity-25.56%
Return on Assets-16.41%
Shares Outstanding49.22M
Shares Float42.26M
Beta0.63
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 2 analystsTarget 8.25
  • Strong Buy
    2

Ownership Breakdown

Institutions
10.54%
Insiders
2.86%
Retail / Other
86.60%

Top Institutional Holders

  • Essex Woodlands Health Ventures
    1.11M2.25%
  • BlackRock Inc
    705.95K1.43%
  • Citigroup Inc
    635.72K1.29%
  • Vanguard Capital Management, LLC
    611.04K1.24%
  • Geode Capital Management, LLC
    543.84K1.10%
  • Vanguard Fiduciary Trust Co
    280.62K0.57%
  • UBS Group AG
    222.20K0.45%
  • State Street Corp
    193.70K0.39%
  • Renaissance Technologies Corp
    189.90K0.39%
  • Barclays PLC
    162.90K0.33%
  • Northern Trust Corp
    133.16K0.27%
  • Jane Street Group LLC
    87.08K0.18%
  • Bank of New York Mellon Corp
    78.28K0.16%
  • Charles Schwab Investment Management Inc
    71.51K0.15%
  • Bridgeway Capital Management, LLC
    56.03K0.11%

Top Fund Holders

  • Fidelity Extended Market Index
    251.21K0.51%
  • iShares Micro-Cap ETF
    157.93K0.32%
  • Fidelity Total Market Index
    87.58K0.18%
  • Schwab Total Stock Market Index
    71.51K0.15%
  • Fidelity Series Total Market Index
    68.41K0.14%